CVS Health Corporation exhibits strong market positioning as a comprehensive healthcare services provider. Despite some investment volatility, the company’s solid market fundamentals and broad client base promise potential for long-term investors. However, careful consideration of its debt-to-equity ratio is suggested.
The company's fundamental ratings show a balanced performance, with notable strengths in discounted cash flow and price-to-book ratios.
| Category | Score | |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 3 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 4 |
Comparing historical scores provides insight into the company's consistent cash flow strength and stable returns on equity and assets.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-06-12 | 3 | 5 | 3 | 4 | 1 | 1 | 4 |
| N/A | 0 | 5 | 3 | 4 | 1 | 1 | 4 |
Recent analyst price targets for CVS Health suggest a positive outlook with a strong median estimate.
| High | Low | Median | Consensus |
|---|---|---|---|
| 115 | 90 | 106 | 103.64 |
The general consensus among analysts indicates a strong buy, reflecting a robust outlook in the current market context.
| Recommendation | Count | |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 33 | |
| Hold | 6 | |
| Sell | 0 | |
| Strong Sell | 0 |
CVS Health Corporation presents a compelling case for investment, driven by its strategic positioning in the healthcare industry and robust service offerings. Its consistent cash flow and earnings performance offer a sense of stability. However, potential investors should be wary of the company's debt levels and ongoing market volatility. Overall, the consensus on CVS suggests a favorable bias, making it a notable option for growth-focused investors.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.